Literature DB >> 24876593

What Are the Next Steps in Continuous Glucose Monitoring?

Volker Lodwig1, Bernhard Kulzer2, Oliver Schnell3, Lutz Heinemann4.   

Abstract

The development of glucose sensors for continuous glucose monitoring (CGM) is likely still in its early days. A number of novel approaches-along with many attempts to improve current CGM systems-are in development. The next generation of glucose sensors (NGGS) will also enable, for example, reliable glucose measurement in the low glycemic range. NGGS systems represent an important step forward for closed-loop systems. This commentary discusses a number of aspects that are relevant in this context.
© 2014 Diabetes Technology Society.

Entities:  

Keywords:  Glucose sensors; artificial pancreas; continuous glucose monitoring; diabetes therapy; hypoglycemia; quality of life

Year:  2014        PMID： 24876593      PMCID： PMC4455401          DOI： 10.1177/1932296814525825

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


  9 in total

1.  Intensive insulin therapy in critically ill patients.

Authors:  G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  AP@home: a novel European approach to bring the artificial pancreas home.

Authors:  Lutz Heinemann; Carsten Benesch; J Hans DeVries
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

3.  Evaluation of the performance of a novel system for continuous glucose monitoring.

Authors:  Eva Zschornack; Christina Schmid; Stefan Pleus; Manuela Link; Hans-Martin Klötzer; Karin Obermaier; Michael Schoemaker; Monika Strasser; Gerhard Frisch; Günther Schmelzeisen-Redeker; Cornelia Haug; Guido Freckmann
Journal:  J Diabetes Sci Technol       Date:  2013-07-01

4.  Performance evaluations of continuous glucose monitoring systems: precision absolute relative deviation is part of the assessment.

Authors:  Karin Obermaier; Günther Schmelzeisen-Redeker; Michael Schoemaker; Hans-Martin Klötzer; Harald Kirchsteiger; Heino Eikmeier; Luigi del Re
Journal:  J Diabetes Sci Technol       Date:  2013-07-01

Review 5.  Overview of a novel sensor for continuous glucose monitoring.

Authors:  Günther Schmelzeisen-Redeker; Arnulf Staib; Monika Strasser; Ulrich Müller; Michael Schoemaker
Journal:  J Diabetes Sci Technol       Date:  2013-07-01

6.  Use of the site of subcutaneous insulin administration for the measurement of glucose in patients with type 1 diabetes.

Authors:  Stefan Lindpointner; Stefan Korsatko; Gerd Köhler; Hans Köhler; Roland Schaller; Ruthy Kaidar; Ofer Yodfat; Lukas Schaupp; Martin Ellmerer; Thomas R Pieber; Werner Regittnig
Journal:  Diabetes Care       Date:  2009-12-29       Impact factor: 17.152

7.  Glucose levels at the site of subcutaneous insulin administration and their relationship to plasma levels.

Authors:  Stefan Lindpointner; Stefan Korsatko; Gerd Köhler; Hans Köhler; Roland Schaller; Lukas Schaupp; Martin Ellmerer; Thomas R Pieber; Werner Regittnig
Journal:  Diabetes Care       Date:  2010-01-22       Impact factor: 17.152

8.  Real-time improvement of continuous glucose monitoring accuracy: the smart sensor concept.

Authors:  Andrea Facchinetti; Giovanni Sparacino; Stefania Guerra; Yoeri M Luijf; J Hans DeVries; Julia K Mader; Martin Ellmerer; Carsten Benesch; Lutz Heinemann; Daniela Bruttomesso; Angelo Avogaro; Claudio Cobelli
Journal:  Diabetes Care       Date:  2012-11-19       Impact factor: 19.112

9.  Analysis of glucose responses to automated insulin suspension with sensor-augmented pump therapy.

Authors:  Trang T Ly; Jennifer A Nicholas; Adam Retterath; Elizabeth A Davis; Timothy W Jones
Journal:  Diabetes Care       Date:  2012-05-14       Impact factor: 19.112
  9 in total
  6 in total

1.  Insulin Pump and CGM Usage in the United States and Germany: Results of a Real-World Survey With 985 Subjects.

Authors:  John Walsh; Ruth Roberts; Dietmar Weber; Gabriele Faber-Heinemann; Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2015-06-12

Review 2.  Technology Use in Transition-Age Patients With Type 1 Diabetes: Reality and Promises.

Authors:  Evan Los; Jenae Ulrich; Ines Guttmann-Bauman
Journal:  J Diabetes Sci Technol       Date:  2016-05-03

Review 3.  Point-of-care diagnostics to improve maternal and neonatal health in low-resource settings.

Authors:  Catherine E Majors; Chelsey A Smith; Mary E Natoli; Kathryn A Kundrod; Rebecca Richards-Kortum
Journal:  Lab Chip       Date:  2017-10-11       Impact factor: 6.799

4.  Routine use of continuous glucose monitoring in 10 501 people with diabetes mellitus.

Authors:  T Battelino; S Liabat; H J Veeze; J Castañeda; A Arrieta; O Cohen
Journal:  Diabet Med       Date:  2015-07-14       Impact factor: 4.359

Review 5.  A Review of the Current Challenges Associated with the Development of an Artificial Pancreas by a Double Subcutaneous Approach.

Authors:  Sverre Christian Christiansen; Anders Lyngvi Fougner; Øyvind Stavdahl; Konstanze Kölle; Reinold Ellingsen; Sven Magnus Carlsen
Journal:  Diabetes Ther       Date:  2017-05-13       Impact factor: 2.945

Review 6.  Artificial Pancreas or Novel Beta-Cell Replacement Therapies: a Race for Optimal Glycemic Control?

Authors:  Michiel F Nijhoff; Eelco J P de Koning
Journal:  Curr Diab Rep       Date:  2018-09-24       Impact factor: 4.810
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.